We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5B
AUM Growth
-$515M
Cap. Flow
-$868M
Cap. Flow %
-17.36%
Top 10 Hldgs %
42.58%
Holding
90
New
18
Increased
21
Reduced
23
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 37.84%
2 Communication Services 11.85%
3 Materials 8.94%
4 Consumer Discretionary 8.09%
5 Technology 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCOM icon
26
Trip.com Group
TCOM
$27.5B
$73M 1.46%
2,278,444
+434,026
+24% +$11.7M
MSFT icon
27
Microsoft
MSFT
$2.84T
$71.3M 1.43%
+1,709,353
New +$69.2M
MHFI
28
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$67.1M 1.34%
808,358
-395,317
-33% -$31.2M
HAL icon
29
Halliburton
HAL
$27.9B
$65.9M 1.32%
928,465
-1,506,342
-62% -$96.5M
TIBX
30
DELISTED
TIBCO SOFTWARE INC
TIBX
$65.8M 1.32%
+3,262,087
New +$65.1M
GOOG icon
31
Alphabet (Google) Class C
GOOG
$3.9T
$63M 1.26%
2,171,506
-8,466,338
-80% -$230M
CYH icon
32
Community Health Systems
CYH
$385M
$57.1M 1.14%
+1,522,126
New +$50.6M
SCHW
33
Charles Schwab
SCHW
$177B
$52.1M 1.04%
1,933,036
-3,058,222
-61% -$80.3M
NOW icon
34
ServiceNow
NOW
$102B
$47.8M 0.96%
3,859,175
-1,732,365
-31% -$18.5M
PARA
35
DELISTED
Paramount Global Class B
PARA
$47M 0.94%
756,160
-412,496
-35% -$24.6M
BIDU icon
36
Baidu
BIDU
$35.8B
$43.9M 0.88%
+234,734
New +$38.4M
TEX icon
37
Terex
TEX
$7.98B
$40.8M 0.82%
993,461
-493,747
-33% -$20.1M
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$4.25B
$36.9M 0.74%
1,632,175
+68,740
+4% +$1.44M
KYTH
39
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$36.6M 0.73%
952,715
-50,777
-5% -$1.77M
HNT
40
DELISTED
HEALTH NET INC
HNT
$34.5M 0.69%
829,757
-1,354,096
-62% -$50.4M
KPTI icon
41
Karyopharm Therapeutics
KPTI
$168M
$30.9M 0.62%
44,189
+23,550
+114% +$11M
OREX
42
DELISTED
Orexigen Therapeutics, Inc.
OREX
$28.5M 0.57%
460,496
-52,417
-10% -$3.05M
THC icon
43
Tenet Healthcare
THC
$20.1B
$27.3M 0.55%
581,714
-580,934
-50% -$26.3M
PHM icon
44
Pultegroup
PHM
$24.5B
$26.7M 0.53%
+1,322,987
New +$25.4M
VNET
45
VNET Group
VNET
$2.05B
$23.6M 0.47%
+788,626
New +$20.7M
HUM icon
46
Humana
HUM
$46.7B
$21.9M 0.44%
171,614
-160,769
-48% -$19M
TMO icon
47
Thermo Fisher Scientific
TMO
$211B
$21M 0.42%
178,193
-458,563
-72% -$54M
MOH icon
48
Molina Healthcare
MOH
$10.3B
$19M 0.38%
426,202
-351,915
-45% -$14.3M
ANAC
49
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$18.8M 0.38%
1,061,161
+34,416
+3% +$554K
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
$18.4M 0.37%
444,734
-632,086
-59% -$32.6M

Similar funds

PFM Health Sciences's Q2 2014 Portfolio in Review

As of Q2 2014, PFM Health Sciences held 90 positions worth $5B, down 9.3% from $5.52B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences withdrew a net $868M in Q2 2014, closing 27 positions and reducing 23 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $439M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 46% a quarter earlier, followed by Communication Services and Materials.

Against the trend, PFM Health Sciences opened a new position in Netflix worth $179M.

  • PFM Health Sciences's largest Q2 2014 buy was Netflix: 28,445,060 shares worth $179M.
  • PFM Health Sciences added most to Rite Aid Corporation in Q2 2014, an estimated $221M increase.
  • PFM Health Sciences's biggest Q2 2014 reduction was Alphabet (Google) Class C, cutting an estimated $230M.
  • PFM Health Sciences fully exited iShares MSCI Emerging Markets ETF in Q2 2014, selling an estimated $439M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $5B portfolio in Q2 2014.
  • PFM Health Sciences opened 18 new positions and closed 27 in Q2 2014.
  • PFM Health Sciences's portfolio value fell 9.3% quarter-over-quarter to $5B.

Based on PFM Health Sciences's 13F filing for Q2 2014, filed 14 Aug 2014.